Merck partners Africa’s First Ladies on cancer and fertility care
Merck taps Africa's First Ladies on cancer and fertility care Last week, Africa joined the rest of world in marking...
Paul Adepoju is an academic, journalist, author, geneticist, local content creator and media entrepreneur. He teaches genetics and histopathology at Nigeria's Babcock University and he covers health and tech in Africa for CNN, Quartz and several others. He's also the founder and managing editor of HealthNews.NG and healthnews.africa. He is completing a doctorate in cell biology and genetics at Nigeria's premier university, the University of Ibadan.
Merck taps Africa's First Ladies on cancer and fertility care Last week, Africa joined the rest of world in marking...
We asked our readers what they thought was happening in this picture. Here's the answer. It has to do with...
The cholera outbreak that killed over 400 people within 18 months is over in South Sudan, govt has announced. A...
A unique perspective to Nigeria's peculiar cancer management dilemma Initially promised to be available in January, cancer patients at National...
Here's what you need to know about Nigeria's #YesCHIPS program launched today by President Buhari This afternoon, Nigeria's President Muhammadu Buhari...
Vaccines also help prevent poverty, study shows A new study has revealed that in addition to saving millions of lives,...
New data shows Nigeria ranks 141th on the list government expenditure on health Focus Clinic have produced a map revealing...
Emir of Kano suspends village head over polio immunization sabotage A village head that prevented vaccine volunteers from immunizing children...
To improve healthcare delivery in FG-owned facilities, government has announced special intervention funds According to the health minister Prof. Isaac...
"Elumelu will champion the cause of immunisation in Africa." Prominent African business and healthcare sector leader Dr Awele Elumelu has...
© 2017 HealthNews.NG - Owned by Glumedia Company.